RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,416,000 | +8.3% | 50,313 | +5.8% | 0.01% | +25.0% |
| Q4 2019 | $2,231,000 | +131.2% | 47,546 | +16.5% | 0.00% | +100.0% |
| Q3 2019 | $965,000 | -15.7% | 40,797 | +7.1% | 0.00% | 0.0% |
| Q2 2019 | $1,145,000 | +99.1% | 38,085 | +48.3% | 0.00% | +100.0% |
| Q1 2019 | $575,000 | +52.5% | 25,685 | +23.9% | 0.00% | 0.0% |
| Q4 2018 | $377,000 | +45.6% | 20,725 | +45.0% | 0.00% | 0.0% |
| Q3 2018 | $259,000 | +83.7% | 14,293 | +1.2% | 0.00% | – |
| Q2 2018 | $141,000 | +116.9% | 14,129 | +15.5% | 0.00% | – |
| Q1 2018 | $65,000 | -28.6% | 12,229 | +13.9% | 0.00% | – |
| Q4 2017 | $91,000 | -52.1% | 10,739 | -17.5% | 0.00% | – |
| Q3 2017 | $190,000 | -21.2% | 13,019 | +1.4% | 0.00% | -100.0% |
| Q2 2017 | $241,000 | – | 12,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |